We’re a specialized Clinical Research Organization dedicated to excellence. We efficiently launch studies, enroll diverse patients, and prioritize quality and communication. Join us in reshaping the landscape of clinical research to encourage inclusivity and accessibility for all.

total diversity people (latino guy 1) copy

Pioneers in Inclusive Clinical Research

TOTAL Diversity is a leading clinical research organization with a proven track record in diversity integration. We specialize in studies that embrace diverse populations, using strategies including community outreach and access through technology.

Diversity in Clinical Trials Best Practices and Perspectives for Industry and Clinical Research Sites

Diversity in Clinical Trials, written by Total Diversity key leaders, represents a compilation of evidence-based research and original articles by a variety of experts in the field of diversity in clinical trials. It is a collection of relevant and timely information for the clinical industry today.

To receive a free eBook, complete the contact form

A Full Service CRO and Diversity Organization

total diversity people (mixed girl) copy

The TOTAL Diversity Difference

Decade of CRO Service

Trusted Partners to Clients

Experts in Understanding the Research Sites Perspective

High Level Thought Leaders in Clinical Research and Diversity

Innovation Sets

Us Apart

Extensive Portfolio of Site and Sponsor Support Services

Learn More

Client Success Stories

Inspiring success was achieved in a neurology study using training in diversity as a platform. The integration of The Diversity Site Assessment Tool (DSAT) and DTEACH training modules emerged as a pivotal factor in transforming diversity planning and execution across participating sites. In the pilot program encompassing 40 selected sites, TOTAL achieved an impressive 85% satisfaction rating by sites using the tools.

Click Here

In a recent blood pressure study, the use of cutting-edge app technology led to remarkable success. Emphasizing diversity enrollment, a significant milestone was achieved by attaining 30% representation from upper Fitzpatrick skin types within two months. The site selection strategy emphasizing diverse site capability contributed to the study’s completion five weeks ahead of schedule.

Click Here